# Antipsychotic Effects of Oxytocin

> **NCT01621737** · NA · TERMINATED · sponsor: **University of California, San Diego** · enrollment: 42 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01621737
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** Break in funding
- **Last updated:** 2019-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01621737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01621737, "Antipsychotic Effects of Oxytocin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01621737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*